Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data
- PMID: 30763292
- PMCID: PMC6488219
- DOI: 10.1097/QAI.0000000000001925
Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data
Abstract
Background: Under the Affordable Care Act, hospitals receive reduced reimbursements for excessive 30-day readmissions. However, the Centers for Medicare and Medicaid Services does not consider social and behavioral variables in expected readmission rate calculations, which may unfairly penalize systems caring for socially disadvantaged patients, including patients with HIV.
Setting: Randomized controlled trial of patient navigation with or without financial incentives in HIV-positive substance users recruited from the inpatient setting at 11 US hospitals.
Methods: External validation of an existing 30-day readmission prediction model, using variables available in the electronic health record (EHR-only model), in a new multicenter cohort of HIV-positive substance users was assessed by C-statistic and Hosmer-Lemeshow testing. A second model evaluated sociobehavioral factors in improving the prediction model (EHR-plus model) using multivariable regression and C-statistic with cross-validation.
Results: The mean age of the cohort was 44.1 years, and participants were predominantly males (67.4%), non-white (88.0%), and poor (62.8%, <$20,000/year). Overall, 17.5% individuals had a hospital readmission within 30 days of initial hospital discharge. The EHR-only model resulted in a C-statistic of 0.65 (95% confidence interval: 0.60 to 0.70). Inclusion of additional sociobehavioral variables, food insecurity and readiness for substance use treatment, in the EHR-plus model resulted in a C-statistic of 0.74 (0.71 after cross-validation, 95% confidence interval: 0.64 to 0.77).
Conclusions: Incorporation of detailed social and behavioral variables substantially improved the performance of a 30-day readmission prediction model for hospitalized HIV-positive substance users. Our findings highlight the importance of social determinants in readmission risk and the need to ask about, adjust for, and address them.
Conflict of interest statement
Conflicts of interest:
AN receives research funds from Gilead Sciences FOCUS program.
Figures
References
-
- Nijhawan AE, Clark C, Kaplan R, et al. An electronic medical record-based model to predict 30-day risk of readmission and death among HIV-infected inpatients. J Acquir Immune Defic Syndr. 2012;61(3):349–358. - PubMed
-
- Amarasingham R, Moore BJ, Tabak YP, et al. An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care. 2010;48(11):981–988. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AI050409/AI/NIAID NIH HHS/United States
- UG1 DA013034/DA/NIDA NIH HHS/United States
- UG1 DA015815/DA/NIDA NIH HHS/United States
- UG1 DA013720/DA/NIDA NIH HHS/United States
- U10 DA020036/DA/NIDA NIH HHS/United States
- P30 MH043520/MH/NIMH NIH HHS/United States
- U10 DA020024/DA/NIDA NIH HHS/United States
- UG1 DA013727/DA/NIDA NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- Z01 AI005040/ImNIH/Intramural NIH HHS/United States
- U10 DA013720/DA/NIDA NIH HHS/United States
- UG1 DA020024/DA/NIDA NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- U10 DA015831/DA/NIDA NIH HHS/United States
- U10 DA013035/DA/NIDA NIH HHS/United States
- P30 AI073961/AI/NIAID NIH HHS/United States
- UG1 DA015831/DA/NIDA NIH HHS/United States
- UG1 DA013035/DA/NIDA NIH HHS/United States
- HHSN271201400028C/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- K23 AI112477/AI/NIAID NIH HHS/United States
- U10 DA013043/DA/NIDA NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- R34 DA045592/DA/NIDA NIH HHS/United States
- U10 DA013045/DA/NIDA NIH HHS/United States
- U10 DA013034/DA/NIDA NIH HHS/United States
- U10 DA013727/DA/NIDA NIH HHS/United States
- R24 HS022418/HS/AHRQ HHS/United States
- UG1 DA013732/DA/NIDA NIH HHS/United States
- HHSN271201000024C/DA/NIDA NIH HHS/United States
- U10 DA015815/DA/NIDA NIH HHS/United States
- HHSN271200900034C/DA/NIDA NIH HHS/United States